Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.00    -3.20 (-3.10%)
Bid:
100.20
Ask:
102.00
Spread: 1.80 (1.796%)
Market Cap: £163.94m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

19 Oct 2009 07:00

RNS Number : 9424A
Yule Catto & Co PLC
19 October 2009
 



Yule Catto & Co plc 

Interim Management Statement

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its interim management statement for the period 1 July to 30 September 2009.

The Group delivered a strong financial performance in the third quarter, exceeding the expectations of the Board at the time of its Interim Report.

In Polymer Chemicals, monomer prices increased as expected. Volumes, which were almost 15% down in the first half of the year, were less than 10% down in the quarter compared to quarter three 2008, bettering the anticipated 10-15% decline. This, together with continued good cost control and the weak pound, meant Polymers delivered a strong third quarter.

Pharma Chemicals is seasonally weak in the third quarter due to the summer shutdown period in continental Europe. We continued to see the lower volumes in the business that we experienced through the first half, but the business remains ahead of prior year as at the end of September. 

William Blythe's performance was in line with the first half of the current year, and is well ahead of last year for the nine month period.

The Group announced a number of cost reduction initiatives with its full year 2008 results which have delivered as planned.

Good progress was made on reducing Group net debt, which fell further during the quarter. In September the Group repaid the £33M current installment of its term loans, without recourse to its three year £30M revolving bank loan facility arranged in December 2008, which remained undrawn as at the end of September.

With the strong third quarter, Group profit before tax at the nine months is now well ahead of the same period last year. Raw material price rises are putting pressure on margins, and we are working to recover this through selling prices and this looks likely to persist throughout 2010. Substantial uncertainty about the global economic situation clearly remains. There has been some customer restocking during the first nine months, and whilst Polymer volumes will be ahead for the fourth quarter, we remain cautious about volume development in 2010. For the current year though, following the strong third quarter performance of the Group, the Board now expects full year underlying profit before tax for the group to substantially exceed 2008.

19 October 2009

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

Hogarth Partnership Limited

Tel: 020 7357 9477

Andrew Jaques

John Olsen

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFESIALRLIA
Date   Source Headline
2nd Jan 20259:00 amRNSDirectorate Change
31st Oct 20247:00 amRNSTrading statement - Autumn 2024
17th Oct 20244:01 pmRNSHolding(s) in Company
14th Oct 20241:51 pmRNSHolding(s) in Company
27th Sep 202412:46 pmRNSHolding(s) in Company
19th Sep 20241:01 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSInterim results
18th Jul 202412:53 pmRNSChair succession and other board changes
17th May 20248:20 amRNSPost Stabilisation Notice
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.